Few cancer subtypes have evolved as dramatically as HER2-positive breast cancer.
This clip reflects on decades of progress — from early trastuzumab data to today’s antibody-drug conjugates — and why innovation in this space continues to reshape what cure looks like.
HER2+ Breast Cancer: The Most Transformed Disease in Oncology?
You may also like
Recommended Videos
